BRUTTOMESSO, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 4.812
EU - Europa 561
AS - Asia 349
OC - Oceania 5
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.730
Nazione #
US - Stati Uniti d'America 4.810
CN - Cina 270
IT - Italia 217
FI - Finlandia 90
SE - Svezia 88
DE - Germania 58
VN - Vietnam 54
GB - Regno Unito 35
UA - Ucraina 23
IN - India 19
FR - Francia 17
NL - Olanda 7
RU - Federazione Russa 6
IE - Irlanda 5
PT - Portogallo 4
AU - Australia 3
CH - Svizzera 3
ES - Italia 3
KR - Corea 3
BR - Brasile 2
DK - Danimarca 2
NZ - Nuova Zelanda 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
BG - Bulgaria 1
CA - Canada 1
EU - Europa 1
JP - Giappone 1
MX - Messico 1
RO - Romania 1
SG - Singapore 1
Totale 5.730
Città #
Fairfield 819
Chandler 516
Woodbridge 428
Houston 391
Ashburn 347
Ann Arbor 333
Cambridge 312
Seattle 303
Wilmington 266
Jacksonville 108
Princeton 98
Beijing 87
San Diego 87
Padova 86
Des Moines 76
Medford 65
Dong Ket 54
Boardman 49
Roxbury 47
Helsinki 39
Nanjing 30
Modena 28
Dearborn 27
New York 24
Shenyang 20
Guangzhou 16
Nanchang 15
Redwood City 14
Hebei 12
Shanghai 12
London 11
Tianjin 10
Jiaxing 9
Changsha 8
Hefei 7
Kunming 7
Norwalk 7
Milan 5
Ningbo 5
Rome 5
Scafati 5
Washington 5
Zhengzhou 5
Dublin 4
Kharkiv 4
Ashland 3
Berkeley 3
Bern 3
Bielefeld 3
Detroit 3
Goyang-si 3
Jinan 3
Ogden 3
Orange 3
Prescot 3
Arzignano 2
Atessa 2
Bloomington 2
Borås 2
Cassola 2
Castel Maggiore 2
Chengdu 2
Chicago 2
Chiswick 2
Fuzhou 2
Haikou 2
Laion 2
Los Angeles 2
Mohali 2
Monash 2
Neu-Ulm 2
New Bedfont 2
New Haven 2
Newport 2
Parsippany 2
Phoenix 2
Providence 2
Redmond 2
San Severo 2
Taizhou 2
Tarragona 2
Tavagnacco 2
Xi'an 2
Albizzate 1
Amsterdam 1
Auckland 1
Barstow 1
Bensenville 1
Berlin 1
Breganze 1
Buffalo 1
Catanzaro 1
Cedar Lake 1
Cento 1
Charneca De Caparica 1
Chongqing 1
Dallas 1
Delhi 1
Dubai 1
Edinburgh 1
Totale 4.909
Nome #
Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study 158
2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: A randomised crossover trial 154
Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes 145
FreeStyle Libre and Dexcom G4 Platinum sensors: Accuracy comparisons during two weeks of home use and use during experimentally induced glucose excursions 144
Accuracy of a CGM Sensor in Pediatric Subjects With Type 1 Diabetes. Comparison of Three Insertion Sites: Arm, Abdomen, and Gluteus 135
Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study 133
Randomized summer camp crossover trial in 5-to 9-year-old children: Outpatient wearable artificial pancreas is feasible and safe 129
Closed-Loop Artificial Pancreas Using Subcutaneous Glucose Sensing and Insulin Delivery and a Model Predictive Control Algorithm: Preliminary Studies in Padova and Montpellier 128
Parental evaluation of a telemonitoring service for children with Type 1 Diabetes 121
Multinight "Bedside" closed-loop control for patients with type 1 diabetes 120
Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes 117
Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas. 112
Individually Adaptive Artificial Pancreas in Subjects with Type 1 Diabetes: A One-Month Proof-of-Concept Trial in Free-Living Conditions 109
Head-to-head comparison of the accuracy of Abbott FreeStyle Libre and Dexcom G5 mobile 108
null 104
Effects of metabolites and analogs of amiodarone on alveolar macrophages: structure-activity relationship 98
Fully Integrated Artificial Pancreas in Type 1 Diabetes: Modular Closed-Loop Glucose Control Maintains Near Normoglycemia. 96
Real-Time Improvement of Continuous Glucose-Monitoring Accuracy - The smart sensor concept 95
The use of degrees of certainty to evaluate knowledge 89
Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapy 87
Pilot Studies of Wearable Outpatient Artificial Pancreas in Type 1 Diabetes 87
Assessment of patient perceptions about web telemonitoring applied to artificial pancreas use at home 86
Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery 86
First Use of Model Predictive Control in Outpatient Wearable Artificial Pancreas 86
Amiodarone inhibits lung degradation of SP-A and perturbs the distribution of lysosomal enzymes 85
Leucine and phenylalanine kinetics during mixed meal ingestion: a multiple tracer approach. 85
Effects of wine intake on postprandial plasma amino acid and protein kinetics in type 1 diabetes 82
Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy 82
Psychological outcomes of evening and night closed-loop insulin delivery under free living conditions in people with Type 1 diabetes: a 2-month randomized crossover trial 81
Fasting and postmeal phenylalanine metabolism in mild type 2 diabetes. 80
Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites. 79
Effects of insulin and amino acid infusion on leucine and phenylalanine kinetics in type 1 diabetes. 79
Day-and-night closed-loop glucose control in patients with type 1 diabetes under free-living conditions:results of a single-arm 1-month experience compared with a previously reported feasibility study of evening and night at home 78
Multinational home use of closed-loop control is safe and effective 75
Overnight Closed-Loop Control Improves Glycemic Control in a Multicenter Study of Adults With Type 1 Diabetes 75
Influence of health locus of control and fear of hypoglycaemia on glycaemic control and treatment satisfaction in people with Type 1 diabetes on insulin pump therapy 73
Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI). 72
Educating diabetic patients about insulin use: changes over time in certainty and correctness of knowledge. 72
Effects of metformin treatment on whole-body and splanchnic amino acid turnover in mild type 2 diabetes. 71
A High-Fiber Diet Decreases Postabsorptive Protein Turnover but Does Not Alter Insulin Sensitivity in Men with Type 1 Diabetes Mellitus. 71
Assessment of the effect of pregnancy planning in women with type 1 diabetes treated by insulin pump 70
Closing the Loop 69
Use of insulin detemir in pregnancy: a report on 10 Type 1 diabetic women 68
The GesTIO protocol experience: safety of a standardized order set for subcutaneous insulin regimen in elderly hospitalized patients 67
Insulin infusion normalizes fasting and postprandial albumin and fibrinogen synthesis in type 1 diabetes mellitus 66
Lipoatrophy Induced by Subcutaneous Insulin Infusion: Ultrastructural Analysis and Gene Expression Profiling 64
Reduction of Hyper- and Hypoglycemia during Two Months with a Wearable Artificial Pancreas from Dinner to Breakfast in Patients with Type 1 Diabetes 62
Accuracy comparison between Dexcom G5 and Eversense sensors 62
Performance of the Steno type 1 risk engine for cardiovascular disease prediction in Italian patients with type 1 diabetes 61
Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type I diabetic patients: A multicenter randomized crossover trial 55
Comparing the accuracy of transcutaneous sensor and 90-day implantable glucose sensor 53
La terapia insulinica sottocutanea continua in Italia. Seconda indagine nazionale 52
The Multi-Modular Model Predictive Control-to-Range (MPC2R) Allows Simultaneous Improvement in Safety and Efficacy of Closed-Loop Insulin Delivery in Type 1 Diabetes (T1D) 51
Il pancreas artificiale in età  pediatrica: Prima esperienza Italiana 51
Effects of Hypoglycemia on Circulating Stem and Progenitor Cells in Diabetic Patients 51
Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy 51
La valutazione dei risultati: conoscenze, comportamenti, end-point terapeutici 50
A randomized crossover study to compare continuous subcutaneous insulin infusion (CSII) with multiple daily injection (MDI) in type 1 diabetic patients previously treated with CSII 50
MULTI-CENTER RANDOMIZED CROSS-OVER ITALIAN PEDIATRIC SUMMER CAMP: AP VS SAP IN 5-9 YEAR OLD CHILDREN 50
The use of real time continuous glucose monitoring or flash glucose monitoring in the management of diabetes: A consensus view of Italian diabetes experts using the Delphi method 50
Psychological aspects of evening and night closed-loop insulin delivery under free living conditions: a 2 months cross-over trial 49
A “Slide Rule” to Adjust Insulin Dose Using Trend Arrows in Adults with Type 1 Diabetes: Test in Silico and in Real Life 47
Artificial Pancreas Improves Glycemic Control in a Multi-night Multicenter Outpatient/Home Study of Patients with T1D 46
THE SOCIAL ACCEPTANCE OF FUTURE ARTIFICIAL PANCREAS TECHNOLOGY: PARENTS' PERCEPTIONS OF PEDARPAN (PEDIATRICS ARTIFICIAL PANCREAS) 46
PERCEIVED UTILITY OF A REMOTE MONITORING SYSTEM FOR PEDIATRIC SUBJECTS AFFECTED BY TYPE 1 DIABETES IN PEDARPAN (PEDIATRICS ARTIFICIAL PANCREAS) SUMMER CAMP 45
Effects of glucose variability on hematopoietic stem/progenitor cells in patients with type 1 diabetes 45
Efficacy of telemedicine for persons with type 1 diabetes during Covid19 lockdown 40
Diabetic ketoacidosis: A consensus statement of the Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology and Pediatric Diabetoloy (SIEDP) 39
Implantable and transcutaneous continuous glucose monitoring system: a randomized cross over trial comparing accuracy, efficacy and acceptance 38
Head to head accuracy comparison between two interstitial glucose sensors 37
A comprehensive in-silico comparison of literature methods to adjust the meal insulin bolus accounting for continuous glucose monitoring rate of change 37
HbA(1c) improvement with less hypoglycaemia in patients with type 1 diabetes wearing an artificial pancreas for two months from dinner to breakfast 35
Protein degradation and synthesis measured with multiple amino acid tracers in post-absorptive and protein-anabolic conditions. 34
Personalized Subcutaneous Model-Predictive Closed-Loop Control of T1DM: Pilot Studies in the USA and Italy 33
Methods for Insulin Bolus Adjustment Based on the Continuous Glucose Monitoring Trend Arrows in Type 1 Diabetes: Performance and Safety Assessment in an In Silico Clinical Trial 31
Assessment and comparison of the measurement error components of Dexcom G5 Mobile and Eversense continuous glucose monitoring systems 30
An Integrated Mobile Platform for Automated Data Collection and Real-Time Patient Monitoring in Diabetes Clinical Trials 29
Artificial pancreas: A review of fundamentals and inpatient and outpatient studies 22
A NEW TELEMEDICINE PLATFORM FOR CLINICAL TRIALS WITH AUTOMATIC SENSOR DATA GATHERING AND REAL TIME MONITORING 21
IMPROVEMENT OF THE CHILDREN POPULATION INCLUDED INTO THE UVA/PADOVA TYPE 1 DIABETES SIMULATOR 18
Effectiveness of adding alarms to flash glucose monitoring in adults with type 1 diabetes under routine care 8
Evaluating the experience of children with type 1 diabetes and their parents taking part in an artificial pancreas clinical trial over multiple days in a diabetes camp setting 6
Totale 5.856
Categoria #
all - tutte 20.082
article - articoli 17.427
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 163
Totale 37.672


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019388 0 0 0 0 0 0 0 0 0 0 190 198
2019/20201.123 156 37 19 95 109 86 140 117 115 112 81 56
2020/20211.129 44 70 16 71 109 82 36 81 132 205 158 125
2021/20221.132 22 97 134 70 84 110 37 127 112 25 68 246
2022/2023946 178 108 29 120 154 126 7 63 104 10 33 14
2023/2024338 16 71 67 42 31 44 14 12 9 32 0 0
Totale 5.856